Testing effectiveness (Phase 2)Study completedNCT01998841
What this trial is testing
Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort
Who this might be right for
Alzheimer's Disease
Genentech, Inc. 252